COMPARISON OF URIC ACID LEVELS AMONG NORMOTENSIVE AND HYPERTENSIVE SUBJECTS

Main Article Content

Sheraz Hassan
Rula Al-Baghdadi
Sajjad Karamat
Nabeel Umer Hussain

Keywords

Hypertension, Uric acid, Hyperuricemia, Normotension, Polyuria

Abstract

Background


Hyperuricemia has been implicated in hypertension and cardiovascular disease, but comparative data remain debated.


 


Objective: To compare serum uric acid levels between normotensive and hypertensive subjects and evaluates associated symptom distributions and gender differences.


 


Methods: A cross‑sectional study of 80 subjects was conducted. This study was conducted at University of Lahore, Lahore. Subjects were classified as hypertensive if systolic blood pressure measured ≥140 mmHg or diastolic blood pressure measured ≥90 mmHg. Serum uric acid levels between two groups were compared using student t-test. Symptom prevalence and gender differences were analyzed using chi‑square and subgroup comparisons.


 


Results: Of 80 subjects, 41 were hypertensive and 39 normotensive subjects. Mean uric acid was significantly higher in hypertensive subjects (6.3 ± 0.23 mg/dL) compared to normotensive subjects (4.9 ± 0.18 mg/dL, p<0.05). Joint pain (p=0.03), polyuria (p=0.04), and general weakness (p=0.05) were more prevalent in hypertensive individuals. Hypertensive males showed significantly higher uric acid levels (6.6 ± 0.28 mg/dL) compared to hypertensive females (6.0 ± 0.30 mg/dL, p=0.04).


Conclusion: Raised uric acid levels are significantly linked with high blood pressure and symptom burden.


 

Abstract 0 | pdf Downloads 0

References

1. World Health Organization. Hypertension fact sheet. Geneva: WHO; 2023.
2. Borghi C, Agnoletti D, Cicero AF, Lurbe E, Virdis A. Uric acid and hypertension: review. Hypertension. 2022;79(6):1926 36.
3. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811 21.
4. Miricescu D, Totan A, Stanescu II, Badoiu SC, Greabu M. Hyperuricemia, endothelial dysfunction and hypertension. Ro J Med Pract. 2020;15(2):97 104.
5. Kelley EE, Khoo NK, Hundley NJ, Malik UZ, Freeman BA, Tarpey MM. Oxidative stress and uric acid. Am J Hypertens. 2020;33(7):583 94.
6. Feig DI, Johnson RJ, Kang DH. Uric acid and hypertension in adolescents. JAMA. 2003;290(13):1873 9.
7. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in rats. Hypertension. 2001;38(5):1101 6.
8. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: meta analysis. Arthritis Care Res. 2011;63(1):102 10.
9. Pakistan Hypertension League. National prevalence survey of hypertension in Pakistan. Pak J Med Sci. 2018;34(5):1052 7.
10. Hussain M, Ghori MU, Aslam MN, Abbas S, Shafique M, Awan FR. Serum uric acid: an independent risk factor for cardiovascular disease in Pakistani Punjabi patients. BMC Cardiovasc Disord. 2024;24:112.
11. Khaliq A, Tariq AM, Khattak AL, Ali K, Satti SA, Rehman HY. Association of hyperuricemia with hypertension in Pakistani population. J Bahria Univ Med Dent Coll. 2020;10(2):98 101.
12. Sánchez Lozada LG, Rodríguez Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, et al. Uric acid and hypertension update. Am J Hypertens. 2020;33(7):583 94.
13. Borghi C, Agnoletti D, Cicero AF, Lurbe E, Virdis A. Uric acid lowering and blood pressure. Hypertension. 2022;79(6):1926 36.
14. Lanaspa MA, Kuwabara M, Andres Hernando A, Johnson RJ. Trials of uric acid lowering. Nat Rev Nephrol. 2023;19(1):45 56.
15. Choi HK, Ford ES, Li C, Curhan G. Uric acid lowering and metabolic syndrome. Arthritis Rheum. 2007;57(1):109 15.
16. Perticone M, Sciacqua A, Maio R, Miceli S, Pascale A, Grassi G, et al. Sex differences for uric acid in hypertension. Cardiovasc Diabetol. 2023;22:298.
17. Salim A, Khan M, Raza S, Ahmed T, Malik F, et al. Sex specific associations between uric acid and hypertension. Eur Heart J. 2023;44(Suppl 2):ehad655.2325.
18. Redon P, Cea Calvo L, Lozano JV, Martí Canales JC, Llisterri JL, Aznar J, et al. Gender differences in uric acid in treated hypertensive patients. J Hypertens. 2019;37(2):380 8.
19. Wu J, Li Y, Zhang Y, Chen X, Zhou Q, et al. Antihypertensive drugs for hyperuricemia: meta analysis. BMC Cardiovasc Disord. 2025;25:856.
20. Wang JJ, Chen L, Zhao Y, Xu H, et al. Systematic review of uric acid and cardiovascular disease. Front Cardiovasc Med. 2025;12:1577952.
21. Cui K, Li Y, Zhang Y, Zhao J, et al. Uric acid and prognosis in coronary artery disease. J Am Heart Assoc. 2023;12:e030625.